Logo image of RARE

ULTRAGENYX PHARMACEUTICAL IN (RARE) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:RARE - US90400D1081 - Common Stock

24.6 USD
+0.29 (+1.19%)
Last: 1/27/2026, 4:10:12 PM
24.62 USD
+0.02 (+0.08%)
After Hours: 1/27/2026, 4:10:12 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RARE revenue by date.RARE revenue by date.
363.3M
3.39%
434.249M
19.53%
560.23M
29.01%
673.25M
20.17%
801.82M
19.10%
1.176B
46.67%
1.575B
33.93%
1.969B
25.02%
2.525B
28.24%
2.571B
1.82%
3.009B
17.04%
3.544B
17.78%
EBITDA
YoY % growth
RARE ebitda by date.RARE ebitda by date.
-630.68M
-71.17%
-543.202M
13.87%
-500.43M
7.87%
-507.557M
-1.42%
-335.002M
34.00%
-74.197M
77.85%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
RARE ebit by date.RARE ebit by date.
-648.9M
-70.00%
-569.208M
12.28%
-535.973M
5.84%
-531.434M
0.85%
-382.316M
28.06%
-121.732M
68.16%
241.53M
298.41%
556.04M
130.22%
980.03M
76.25%
1.108B
13.06%
1.397B
26.08%
1.908B
36.58%
Operating Margin
RARE operating margin by date.RARE operating margin by date.
-178.61%-131.08%-95.67%-78.94%-47.68%-10.35%15.34%28.24%38.81%43.10%46.43%53.84%
EPS
YoY % growth
RARE eps by date.RARE eps by date.
-10.11
-50.67%
-8.33
17.61%
-6.34
23.89%
-5.83
8.03%
-4.10
29.61%
-1.40
65.90%
1.68
219.95%
5.38
220.53%
9.35
73.73%
10.39
11.09%
13.34
28.49%
13.38
0.26%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-1.14
18.21%
-1.61
-2.44%
-1.20
-2.27%
-1.11
38.52%
-0.73
35.97%
-0.94
41.65%
-0.23
80.39%
0.06
105.50%
0.67
192.48%
Revenue
Q2Q % growth
198.78M
20.56%
175.58M
26.05%
190.49M
14.41%
200.23M
25.20%
234.81M
18.13%
213.48M
21.59%
278.32M
46.11%
311.54M
55.59%
389.47M
65.87%
EBITDA
Q2Q % growth
-107.951M
-24.46%
-100.925M
24.65%
-95.827M
-6.15%
-94.626M
34.59%
-101.325M
6.14%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-107.3M
12.25%
-124.472M
12.92%
-110.753M
-2.66%
-104.008M
39.14%
-95.236M
11.24%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.81
-29.29%
-1.26-0.55-43.75%
Q2 2025
Q2Q % growth
-1.17
23.03%
-1.320.1511.68%
Q1 2025
Q2Q % growth
-1.57
22.66%
-1.650.084.60%
Q4 2024
Q2Q % growth
-1.39
8.55%
-1.32-0.07-5.63%
Q3 2024
Q2Q % growth
-1.40
37.22%
-1.480.085.37%
Q2 2024
Q2Q % growth
-1.52
32.44%
-1.730.2112.01%
Q1 2024
Q2Q % growth
-2.03
12.88%
-1.77-0.26-14.94%
Q4 2023
Q2Q % growth
-1.52
29.63%
-1.650.137.99%
Q3 2023
Q2Q % growth
-2.23
36.29%
-2.12-0.11-5.20%
Q2 2023
Q2Q % growth
-2.25
0.44%
-2.12-0.13-6.35%
Q1 2023
Q2Q % growth
-2.33
-6.39%
-2.02-0.31-15.58%
Q4 2022
Q2Q % growth
-2.16
-20.67%
-2.180.021.14%
Q3 2022
Q2Q % growth
-3.50
-224.07%
-1.85-1.65-89.21%
Q2 2022
Q2Q % growth
-2.26
-24.86%
-1.79-0.47-26.47%
Q1 2022
Q2Q % growth
-2.19
-7.88%
-1.80-0.39-21.97%
Q4 2021
Q2Q % growth
-1.79
-383.78%
-1.37-0.42-30.74%
Q3 2021
Q2Q % growth
-1.08
4.42%
-1.440.3624.80%
Q2 2021
Q2Q % growth
-1.81
-541.46%
-1.36-0.45-33.07%
Q1 2021
Q2Q % growth
-2.03
-6.28%
-1.26-0.77-60.89%
Q4 2020
Q2Q % growth
-0.37 -1.180.8168.76%
Q3 2020
Q2Q % growth
-1.13 -1.280.1511.98%
Q2 2020
Q2Q % growth
0.41 -1.571.98126.03%
Q1 2020
Q2Q % growth
-1.91 -1.72-0.19-11.34%
RARE Yearly EPS VS EstimatesRARE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5 10 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
159.933M
14.65%
170.04M-10.107M-5.94%
Q2 2025
Q2Q % growth
166.496M
13.24%
164.82M1.676M1.02%
Q1 2025
Q2Q % growth
139.292M
27.99%
146.7M-7.408M-5.05%
Q4 2024
Q2Q % growth
164.877M
29.42%
158.5M6.377M4.02%
Q3 2024
Q2Q % growth
139.494M
42.27%
138.51M984K0.71%
Q2 2024
Q2Q % growth
147.026M
35.75%
125.64M21.386M17.02%
Q1 2024
Q2Q % growth
108.833M
8.30%
118.33M-9.497M-8.03%
Q4 2023
Q2Q % growth
127.392M
23.32%
121.77M5.622M4.62%
Q3 2023
Q2Q % growth
98.052M
8.11%
111.82M-13.768M-12.31%
Q2 2023
Q2Q % growth
108.309M
21.29%
106.9M1.409M1.32%
Q1 2023
Q2Q % growth
100.496M
25.78%
106.78M-6.284M-5.88%
Q4 2022
Q2Q % growth
103.3M
23.86%
107.22M-3.92M-3.66%
Q3 2022
Q2Q % growth
90.7M
11.15%
98.121M-7.421M-7.56%
Q2 2022
Q2Q % growth
89.3M
2.64%
89.265M35K0.04%
Q1 2022
Q2Q % growth
79.9M
-19.62%
85.327M-5.427M-6.36%
Q4 2021
Q2Q % growth
83.4M
-8.85%
85.471M-2.071M-2.42%
Q3 2021
Q2Q % growth
81.6M
0.12%
83.178M-1.578M-1.90%
Q2 2021
Q2Q % growth
87M
41.00%
87.6M-600K-0.68%
Q1 2021
Q2Q % growth
99.4M
173.83%
78.58M20.82M26.50%
Q4 2020
Q2Q % growth
91.5M 71.955M19.545M27.16%
Q3 2020
Q2Q % growth
81.5M 56.107M25.393M45.26%
Q2 2020
Q2Q % growth
61.7M 39.901M21.799M54.63%
Q1 2020
Q2Q % growth
36.3M 37.477M-1.177M-3.14%
RARE Yearly Revenue VS EstimatesRARE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS4.74% 3.48% 0.63% -13.35%
Revenue3.79% 6.04% 0.91% 0.44%